| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0022-3476(80)80479-3 |
| P698 | PubMed publication ID | 7400889 |
| P2093 | author name string | S Borden | |
| H Rasmussen | |||
| R Baron | |||
| M E Norman | |||
| A T Mazur | |||
| A Gruskin | |||
| C Anast | |||
| P2860 | cites work | Deterioration of renal function during treatment of chronic renal failure with 1,25-dihydroxycholecalciferol | Q28318336 |
| Calcium metabolism in newborn infants. The interrelationship of parathyroid function and calcium, magnesium, and phosphorus metabolism in normal, "sick," and hypocalcemic newborns | Q34464656 | ||
| Decrease in serum immunoreactive parathyroid hormone in rats and in parathyroid hormone secretion in vitro by 1,25-dihydroxycholecalciferol | Q34481720 | ||
| 1,25-dihydroxycholecalciferol in renal osteodystrophy. Epiphysiolysis--anticonvulsant therapy | Q34985705 | ||
| Vitamin D Metabolism and Function | Q37771767 | ||
| Controlled trial of 1apha-hydroxycholecalciferol in chronic renal failure | Q39377600 | ||
| Variable response to long-term 1alpha-hydroxycholecalciferol in haemodialysis osteodystrophy | Q39377938 | ||
| Vitamin-D deficiency in the osteomalacia of chronic renal failure | Q39409715 | ||
| Long-term effects of small doses of 1,25-dihydroxycholecalciferol in renal osteodystrophy | Q39481173 | ||
| Normal plasma-1,25-(OH)2-vitamin-D concentrations in nutritional osteomalacia | Q39550794 | ||
| Basic and clinical concepts related to vitamin D metabolism and action (first of two parts). | Q39704246 | ||
| Basic and clinical concepts related to vitamin D metabolism and action (second of two parts). | Q39704284 | ||
| Statural growth of children with renal disease | Q39783254 | ||
| Metabolism of parathyroid hormone: physiologic and clinical significance | Q39870520 | ||
| A Review: Short Stature in Renal Disease | Q39960216 | ||
| Secondary hyperparathyroidism in chronic renal failure. The clinical spectrum in uremia, during hemodialysis, and after renal transplantation | Q39985647 | ||
| Increased Growth after Long-Term Oral 1α,25-Vitamin D3in Childhood Renal Osteodystrophy | Q40119457 | ||
| Competitive protein-binding radioassay for 25-hydroxycholecalciferol | Q43791446 | ||
| The Efficacy of Calcifediol in Renal Osteodystrophy | Q44802444 | ||
| Effects of 25-hydroxycholecalciferol on bone lesions of children with terminal renal failure | Q45360376 | ||
| GROWTH ABERRATIONS IN RENAL DISEASE. | Q53964705 | ||
| Influence of immunoheterogeneity of circulating parathyroid hormone on results of radioimmunoassays of serum in man. | Q54009692 | ||
| Is calcitriol [1,25(OH)2D3] harmful to renal function? | Q66928352 | ||
| Serum Immunoreactive Parathyroid Hormone and 25-Hydroxyvitamin D in Patients with Uremic Bone Disease | Q66934685 | ||
| Comparison of 1α-hydroxycholecalciferol and 25-hydroxycholecalciferol in the treatment of renal osteodystrophy: Greater effect of 25-hydroxycholecalciferol on bone mineralization | Q66974311 | ||
| 1α-Hydroxycholecalciferol. Long-Term Treatment of Patients with Uraemic Osteodystrophy | Q67445925 | ||
| Growth pattern and dietary intake of children with chronic renal insufficiency | Q68686222 | ||
| The Treatment of Chronic Renal Failure in Children by Regular Dialysis and by Transplantation | Q93748443 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | renal osteodystrophy | Q822598 |
| P1104 | number of pages | 7 | |
| P304 | page(s) | 226-232 | |
| P577 | publication date | 1980-08-01 | |
| P1433 | published in | The Journal of Pediatrics | Q7743611 |
| P1476 | title | Early diagnosis of juvenile renal osteodystrophy | |
| P478 | volume | 97 |
| Q70314404 | 25-hydroxyvitamin D3 (calcifediol) therapy of juvenile renal osteodystrophy: beneficial effect on linear growth velocity |
| Q36029282 | Are new vitamin D analogues in renal bone disease superior to calcitriol? |
| Q41050221 | Biochemical markers of renal osteodystrophy in pediatric patients undergoing CAPD/CCPD. |
| Q54520114 | Bone disease in pediatric patients undergoing dialysis with CAPD or CCPD |
| Q42224046 | Calcium carbonate is an effective phosphorus binder in children with chronic renal failure |
| Q87041755 | Chapter 3.1: Diagnosis of CKD-MBD: biochemical abnormalities |
| Q37207710 | Chronic Renal Insufficiency in Infants and Children |
| Q39535652 | Chronic renal failure in infants and children |
| Q72107813 | Circulating vitamin D metabolite concentrations in childhood renal diseases |
| Q39731172 | Collaborative studies and controlled clinical trials |
| Q35208799 | Effect of dietary phosphorus on circulating concentrations of 1,25-dihydroxyvitamin D and immunoreactive parathyroid hormone in children with moderate renal insufficiency |
| Q84978295 | Evidence-based practice guideline for the treatment of CKD |
| Q71073870 | Growth retardation and renal osteodystrophy in children with chronic renal failure |
| Q46635125 | Laboratory quality control for a multicenter clinical trial: a report from the Growth Failure in Children with Renal Diseases Study |
| Q80152901 | New PTH assays and renal osteodystrophy |
| Q33539810 | Optimal care of the pediatric end-stage renal disease patient on dialysis |
| Q69029080 | Parenteral calcitriol for treatment of severe renal osteodystrophy in children with chronic renal insufficiency |
| Q79761748 | Prevalence of complications in children with chronic kidney disease according to KDOQI |
| Q44988713 | Protocol of the Growth Failure in Children with Renal Diseases Study |
| Q70487838 | Quantitative bone histology in children with chronic renal failure |
| Q67930332 | Recent developments in vitamin D metabolism and its clinical application for renal disease |
| Q71860453 | Reduced plasma concentration of 1,25-dihydroxyvitamin D in children with moderate renal insufficiency |
| Q71073868 | Renal osteodystrophy in children undergoing continuous ambulatory peritoneal dialysis |
| Q39731133 | Renal osteodystrophy in children: the role of vitamin D, phosphorus, and parathyroid hormone |
| Q72403140 | Serum intact parathyroid hormone and ionised calcium concentration in children with renal insufficiency |
| Q34488869 | Suppression of secondary hyperparathyroidism in children with chronic renal failure by high dose phosphate binders: calcium carbonate versus aluminium hydroxide. |
| Q50101289 | The Use of Vitamin D Metabolites and Analogues in the Treatment of Chronic Kidney Disease |
| Q70435900 | The role of nutrition in the care of children with renal insufficiency |
| Q40130707 | Vitamin D in Bone Disease |
Search more.